Q32 Bio (QTTB)
NASDAQ:QTTB

Q32 Bio (QTTB) Financial Statements

727 Followers

Q32 Bio Financial Overview

Q32 Bio's market cap is currently ―. The company's EPS TTM is $-32.496; its P/E ratio is -1.11; Q32 Bio is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue---$ 354.00K$ 802.00K
Gross Profit---$ 354.00K$ 802.00K
EBIT$ -14.86M$ -2.15M$ -29.58M$ -29.30M$ -26.04M
EBITDA$ -14.57M$ -2.82M$ -30.20M$ -29.70M$ -26.73M
Net Income Common Stockholders$ 1.00M$ -29.40M$ -19.67M$ -35.04M$ -28.84M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 135.31M$ 82.65M$ 103.30M$ 127.07M$ 150.03M
Total Assets$ 152.33M$ 84.56M$ 140.06M$ 169.32M$ 196.78M
Total Debt$ 18.59M$ 1.32M$ 28.34M$ 28.72M$ 29.10M
Net Debt$ -116.72M$ -81.33M$ -74.96M$ -98.35M$ -120.92M
Total Liabilities$ 103.56M$ 11.57M$ 51.85M$ 49.96M$ 45.98M
Stockholders Equity$ 48.77M$ 72.99M$ 88.21M$ 119.40M$ 151.88M
Cash Flow-
Free Cash Flow$ -14.55M$ -21.36M$ -24.60M$ -23.66M$ -26.28M
Operating Cash Flow$ -14.55M$ -21.57M$ -24.94M$ -23.66M$ -26.05M
Investing Cash Flow$ 97.00K$ 31.72M$ -22.76M$ 61.00M$ 31.37M
Financing Cash Flow$ 99.35M$ 14.00K$ 18.00K$ 2.00K$ 150.00K
Currency in USD

Q32 Bio Earnings and Revenue History

Q32 Bio Debt to Assets

Q32 Bio Cash Flow

Q32 Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis